DR6 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ACADIA Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 18.46 EUR -3% Market Closed

Market Cap: €3B

A	ACADIA Pharmaceuticals Inc SWB:DR6	US
E	Eastgroup Properties Inc F:EGO	US
	Sleep Country Canada Holdings Inc F:1S2	CA
C	CIMIC Group Ltd F:LTH	AU
P	Persimmon PLC F:OHP	UK
N	New Stratus Energy Inc F:80N	CA
	Osaka Gas Co Ltd OTC:OSGSF	JP
K	Kruk SA WSE:KRU	PL
E	Enwave Corp DUS:E4U	CA
H	Horiba Ltd DUS:01H	JP
V	Vishay Intertechnology Inc XMUN:VHY	US

Profitability Summary

ACADIA Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Strong 3Y Average Gross Margin

97%

Declining Gross Margin

98% > 92%

Low Operating Margin

10%

Strong 3Y Average Operating Margin

33%

Operating Margin is Increasing

-32% > 10%

Exceptional Net Margin

36%

Strong 3Y Average Net Margin

47%

Net Margin is Increasing

-28% > 36%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

19%

Free Cash Flow Margin is Increasing

-28% > 1%

Exceptional ROE

40%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

88%

ROIC is Increasing

-82% > 834%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.